The household expenditure on medicines and other pharmaceutical products, medical apparatus, and equipment in France is forecasted to steadily increase from 2024 to 2028, reaching a value of 14.19 billion Euros by 2028. This upward trend reflects a consistent annual growth rate. When analyzing trends and variations, it is important to note the actual expenditure stood at 13.67 billion Euros in 2023. The year-on-year variations between 2024 and 2028 show moderate growth, with an average annual growth rate (CAGR) expected to reflect this steady increase over the five-year forecast period.
Future trends to watch for include advancements in medical technology and pharmaceuticals, which could drive household expenditure up even further. Additionally, demographic changes such as an aging population may contribute to increased demand, influencing both policy and market offerings in France.
